US Patent Issued to Astrocyte Pharmaceuticals, The Board of Regents of the University of Texas System on Aug. 19 for "Compounds and methods for treating neurological and cardiovascular conditions" (Connecticut, Texas Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,483, issued on Aug. 19, was assigned to Astrocyte Pharmaceuticals Inc. (Cambridge, Mass.) and The Board of Regents of the University of Texas System (Austin, Texas).

"Compounds and methods for treating neurological and cardiovascular conditions" was invented by William S. Korinek (Mystic, Conn.), James D. Lechleiter (San Antonio) and Theodore E. Liston (Stonington, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries."

The patent was filed on Sept. 21, 2022, un...